Pulmonary effects of short-term exposure to low levels of toluene diisocyanate in asymptomatic subjects

European Respiratory Journal

Volumn 13, Issue 5, 1999, Pages 1144-1150

  Vandenplas, O ^a   Delwiche, J P ^a   Staquet, P ^a   Jamart, J ^a   Bernard, A ^b   Boulanger, J ^c   Delaunois, L ^a   Sibille, Y ^a  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c Fonds des Maladies Professionnelles   (Belgium)

Author keywords

Bronchoalveolar lavage; Occupational disease; Toluene diisocyanate

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; CYTOKINE; IMMUNOGLOBULIN; ISOCYANIC ACID DERIVATIVE; PROTEINASE INHIBITOR; TOLUENE DIISOCYANATE;

AIRWAY CONDUCTANCE; ARTICLE; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; WORK ENVIRONMENT;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CROSS-OVER STUDIES; FEMALE; HUMANS; LUNG; MALE; RESPIRATORY FUNCTION TESTS; SINGLE-BLIND METHOD; TIME FACTORS; TOLUENE 2,4-DIISOCYANATE;

EID: 0033055264     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.13e34.x     Document Type: Article

References (31)

1. Musk AW, Peters JM, Wegman DH. Isocyanates and respiratory disease: current status. Am J Ind Med 1988; 13: 331-349.
2. Vandenplas O, Malo JL, Saetta M, Mapp CE, Fabbri LM. Occupational asthma and extrinsic alveolitis due to isocyanates: current status and perspectives. Br J Ind Med 1993; 50: 213-228.
3. Peters JM, Murphy RLH, Pagnotto LD, Whittenberger JL. Respiratory impairment in workers exposed to "safe" levels of toluene diisocyanate (TDI). Arch Environ Health 1970; 20: 364-367.
4. Wegman DH, Peters JM, Pagnotto LD, Fine LJ. Chronic pulmonary function loss from exposure to toluene diisocyanate. Br J Ind Med 1977; 34: 196-200.
5. Diem JE, Jones RN, Hendrick DJ, et al. Five-year longitudinal study of workers employed in a new toluene diisocyanate manufacturing plant. Am Rev Respir Dis 1982; 126: 420-428.
6. Musk AW, Peters JM, Bernstein L. Absence of respiratory effects on subjects exposed to low concentrations of TDI and MDI-a reevaluation. J Occup Med 1985; 27: 917-920.
7. Jones RN, Rando RJ, Glindmeyer HW, et al. Abnormal lung function in polyurethane foam producers. Weak relationship to toluene diisocyanate exposures. Am Rev Respir Dis 1992; 146: 871-877.
8. American Conference of Governmental Industrial Hygienists. 1995-1996 Threshold limit values (TLVs) for chemical substances and physical agents, and biological exposure indices (BEIs). ACGIH, Cincinnati, Ohio. ((ISBN): 1-882417-11-9). 1995-1996.
9. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clinical Allergy 1977; 7: 235-243.
10. American Thoracic Society. Standardization of spirometry. 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
11. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5-40.
12. European Community for Coal and Steel. Standardization of lung function tests. Bull Eur Physiopath Respir 1983; 19: Suppl. 5, 7-10.
13. Vandenplas O, Depelchin S, Delaunois L, Delwiche JP, Sibille Y. Bronchoalveolar lavage immunoglobulin A and G and antiproteases correlate with changes in diffusion indices during the natural course of pulmonary sarcoidosis. Eur Respir J 1994; 7: 1856-1864.
14. Delacroix DL, Marchandise FX, Francis C, Sibille Y. Alpha-2-macroglobulin, monomeric and polymeric immunoglobulin A, and immunoglobulin M in bronchoalveolar lavage. Am Rev Respir Dis 1985; 132: 829-835.
15. Bernard A, Lauwerys R, Noel A, Vandeleene B, Lambert A. Determination by latex immunoassay of protein 1 in normal and pathological urine. Clin Chim Acta 1991; 201: 231-246.
16. Bernard A, Marchandise FX, Depelchin S, Lauwerys R, Sibille Y. Clara cell protein in serum and bronchoalveolar lavage. Eur Respir J 1992; 5: 1231-1238.
17. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear model. Biometrika 1986; 73: 13-22.
18. Davies CS. A computer program for regression analysis of repeated measures using generalized estimating equations. Comput Meth Prog Biomed 1993; 40: 15-31.
19. Wegman DH, Pagnotto LD, Fine LJ, Peters JM. A dose-response relationship in TDI workers. J Occup Med 1974; 16: 258-260.
20. Vogelmeier C, Baur X, Fruhmann G. Isocyanate-induced asthma: results of inhalation tests with TDI, MDI and methacholine. Int Arch Occup Environ Health 1991; 63: 9-13.
21. Devlin RE, McDonnell WF, Mann R, et al. Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in the lung. Am J Respir Cell Mol Biol 1991; 4: 72-81.
22. Aris RM, Christian D, Hearne PQ, Kerr K, Finkbeiner WE, Balmes JR. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am Rev Respir Dis 1993; 148: 1363-1372.
23. Frampton MW, Finkelstein JN, Roberts NJ, Smeglin AM, Morrow PE, Utell MJ. Effects of nitrogen dioxide exposure on bronchoalveolar lavage proteins in humans. Am J Respir Cell Mol Biol 1989; 1: 499-505.
24. Bosken CH, Hards J, Gatter K, Hogg JC. Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry. Am Rev Respir Dis 1992; 145: 911-917.
25. Sandström T, Helleday R, Bjermer L, Stjernberg N. Effects of repeated exposure to 4 ppm nitrogen dioxide on bronchoalveolar lymphocyte subsets and macrophage in healthy men. Eur Respir J 1992; 5: 1092-1096.
26. Brown WE, Green AH, Karol MH, Alarie YC. Inhibition of cholinesterase activity by isocyanates. Toxicol Appl Pharmacol 1982; 63: 45-52.
27. McKay RT, Brooks SM. Effect of toluene diisocyanate on beta adrenergic receptor function. Biochemical and physiologic studies. Am Rev Respir Dis 1983; 128: 50-53.
28. Sheppard D, Scypinski L. A tachykinin receptor antagonist inhibits and an inhibitor of tachykinin metabolism potentiates toluene diisocyanate-induced airway hyperresponsiveness in guinea pigs. Am Rev Respir Dis 1988; 138: 547-551.
29. Cibulas W, Brooks SM, Murlas CG, Miller ML, McKay RT. Toluene diisocyanate-induced airway hyperreactivity in guinea pigs depleted of granulocytes. J Appl Physiol 1988; 64: 1773-1778.
30. Sheppard D, Thompson JE, Scypinski L, Dusser D, Nadel JA, Borson DB. Toluene diisocyanate increases airway responsiveness to substance P and decreases airway neutral endopeptidase. J Clin Invest 1988; 81: 1111-1115.
31. Mapp CE, Boniotti A, Papi A, et al. The effect of phosphoramidon and epithelium removal on toluene diisocyanate-induced contractions in guinea-pig bronchi. Eur Respir J 1992; 5: 331-333.